DARPA Starts $2 Billion Campaign to Develop Next Wave of AI Technologies

DARPA Starts $2 Billion Campaign to Develop Next Wave of AI Technologies

  • September 9, 2018
Table of Contents

DARPA Starts $2 Billion Campaign to Develop Next Wave of AI Technologies

To address the limitations of the first and second wave AI technologies, DARPA seeks to explore new theories and applications that could make it possible for machines to adapt to changing situations. DARPA sees this next generation of AI as a third wave of technological advance, one of contextual adaptation. To better define a path forward, DARPA is announcing today a multi-year investment of more than $2 billion in new and existing programs called the “AI Next” campaign.

DARPA is currently pursing more than 20 programs that are exploring ways to advance the state-of-the-art in AI, pushing beyond second-wave machine learning techniques towards contextual reasoning capabilities. In addition, more than 60 active programs are applying AI in some capacity, from agents collaborating to share electromagnetic spectrum bandwidth to detecting and patching cyber vulnerabilities. Over the next 12 months, DARPA plans to issue multiple Broad Agency Announcements for new programs that advance the state of the art in AI.

Under AI Next, key areas to be explored may include automating critical DoD business processes, such as security clearance vetting in a week or accrediting software systems in one day for operational deployment; improving the robustness and reliability of AI systems; enhancing the security and resiliency of machine learning and AI technologies; reducing power, data, and performance inefficiencies; and pioneering the next generation of AI algorithms and applications, such as “explainability” and commonsense reasoning.

Source: nextbigfuture.com

Tags :
Share :
comments powered by Disqus

Related Posts

AI System Approved For Diabetic Retinopathy Diagnosis

AI System Approved For Diabetic Retinopathy Diagnosis

A system designed by a University of Iowa ophthalmologist that uses artificial intelligence (AI) to detect diabetic retinopathy without a person interpreting the results earned Food and Drug Administration (FDA) authorization in April, following a clinical trial in primary care offices. Results of that study were published Aug. 28 online in Nature Digital Medicine, offering the first look at data that led to FDA clearance for IDx-DR, the first medical device that uses AI for the autonomous detection of diabetic retinopathy. The clinical trial, which also was the first study to prospectively assess the safety of an autonomous AI system in patient care, compared the performance of IDx-DR to the gold standard diagnostic for diabetic retinopathy, which is the leading cause of vision loss in adults and one of the most severe complications for the 30.3 million Americans living with diabetes.

Read More
Collection of Interactive Machine Learning Examples

Collection of Interactive Machine Learning Examples

Each seed is a machine learning example you can start playing with. Explore, learn and grow them into whatever you like.

Read More